These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 34456731)

  • 1. Role of Specialized Pro-Resolving Mediators in Neuropathic Pain.
    Leuti A; Fava M; Pellegrini N; Maccarrone M
    Front Pharmacol; 2021; 12():717993. PubMed ID: 34456731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specialized Pro-Resolving Mediators as Resolution Pharmacology for the Control of Pain and Itch.
    Ji RR
    Annu Rev Pharmacol Toxicol; 2023 Jan; 63():273-293. PubMed ID: 36100219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possibility of averting cytokine storm in SARS-COV 2 patients using specialized pro-resolving lipid mediators.
    Yasmeen N; Selvaraj H; Lakhawat SS; Datta M; Sharma PK; Jain A; Khanna R; Srinivasan J; Kumar V
    Biochem Pharmacol; 2023 Mar; 209():115437. PubMed ID: 36731803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Use of Specialized Pro-Resolving Mediators in Biomaterial-Based Immunomodulation.
    Sousa AB; Barbosa JN
    J Funct Biomater; 2023 Apr; 14(4):. PubMed ID: 37103313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specialized pro-resolving lipid mediators in endodontics: a narrative review.
    Aubeux D; Peters OA; Hosseinpour S; Tessier S; Geoffroy V; Pérez F; Gaudin A
    BMC Oral Health; 2021 May; 21(1):276. PubMed ID: 34030680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling in resolving inflammatory exudates identifies novel anti-inflammatory and pro-resolving mediators and signals for termination.
    Norling LV; Serhan CN
    J Intern Med; 2010 Jul; 268(1):15-24. PubMed ID: 20497301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPMs exert anti-inflammatory and pro-resolving effects through positive allosteric modulation of the prostaglandin EP4 receptor.
    Alnouri MW; Roquid KA; Bonnavion R; Cho H; Heering J; Kwon J; Jäger Y; Wang S; Günther S; Wettschureck N; Geisslinger G; Gurke R; Müller CE; Proschak E; Offermanns S
    Proc Natl Acad Sci U S A; 2024 Oct; 121(41):e2407130121. PubMed ID: 39365815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of T-Cell Immune Responses by Pro-Resolving Lipid Mediators.
    Perez-Hernandez J; Chiurchiù V; Perruche S; You S
    Front Immunol; 2021; 12():768133. PubMed ID: 34868025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of Specialized Pro-Resolving Lipid Mediators in Autophagy and Inflammation.
    Recchiuti A; Isopi E; Romano M; Mattoscio D
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32927853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The roles of special proresolving mediators in pain relief.
    Zhang LY; Jia MR; Sun T
    Rev Neurosci; 2018 Aug; 29(6):645-660. PubMed ID: 29420307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromodulation, Specialized Proresolving Mediators, and Resolution of Pain.
    Tao X; Lee MS; Donnelly CR; Ji RR
    Neurotherapeutics; 2020 Jul; 17(3):886-899. PubMed ID: 32696274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specialized Proresolving Mediators for Therapeutic Interventions Targeting Metabolic and Inflammatory Disorders.
    Han YH; Lee K; Saha A; Han J; Choi H; Noh M; Lee YH; Lee MO
    Biomol Ther (Seoul); 2021 Sep; 29(5):455-464. PubMed ID: 34162770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specialized Pro-Resolving Mediators in Neuroinflammation: Overview of Studies and Perspectives of Clinical Applications.
    Valente M; Dentoni M; Bellizzi F; Kuris F; Gigli GL
    Molecules; 2022 Jul; 27(15):. PubMed ID: 35956787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specialized Pro-resolving Lipid Mediators and Glial Cells: Emerging Candidates for Brain Homeostasis and Repair.
    Tiberi M; Chiurchiù V
    Front Cell Neurosci; 2021; 15():673549. PubMed ID: 33981203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel mediators and mechanisms in the resolution of infectious inflammation: evidence for vagus regulation.
    Serhan CN; de la Rosa X; Jouvene C
    J Intern Med; 2019 Sep; 286(3):240-258. PubMed ID: 30565762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy?
    Chávez-Castillo M; Ortega Á; Cudris-Torres L; Duran P; Rojas M; Manzano A; Garrido B; Salazar J; Silva A; Rojas-Gomez DM; De Sanctis JB; Bermúdez V
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PCOS: A Chronic Disease That Fails to Produce Adequately Specialized Pro-Resolving Lipid Mediators (SPMs).
    Regidor PA; de la Rosa X; Müller A; Mayr M; Gonzalez Santos F; Gracia Banzo R; Rizo JM
    Biomedicines; 2022 Feb; 10(2):. PubMed ID: 35203665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specialized pro-resolving mediators in cardiovascular diseases.
    Fredman G; Spite M
    Mol Aspects Med; 2017 Dec; 58():65-71. PubMed ID: 28257820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli-driven acute inflammation.
    Motwani MP; Colas RA; George MJ; Flint JD; Dalli J; Richard-Loendt A; De Maeyer RP; Serhan CN; Gilroy DW
    JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolvin D5 Inhibits Neuropathic and Inflammatory Pain in Male But Not Female Mice: Distinct Actions of D-Series Resolvins in Chemotherapy-Induced Peripheral Neuropathy.
    Luo X; Gu Y; Tao X; Serhan CN; Ji RR
    Front Pharmacol; 2019; 10():745. PubMed ID: 31333464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.